ArticleCureus2025
Healthcare Service Disparities in Cancer Rehabilitation and Treatment Costs in Japan: A Cross-Sectional Analysis of National Data.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer rehabilitation is essential for addressing the physical, psychological, and social challenges associated with cancer treatment. It plays a crucial role in mitigating functional impairment and enhancing recovery. However, the patterns of its utilization in relation to different cancer treatment modalities remain insufficiently understood. This study aimed to analyze the utilization of cancer rehabilitation in Japan and examine its association with surgery, chemotherapy, and radiation therapy.
methodsA cross-sectional study was conducted using standardized claims data ratio (SCR) scores from Japan's National Database (NDB) between 2017 and 2021. SCRs for surgery, chemotherapy, radiotherapy, and cancer rehabilitation costs were analyzed across regions. Statistical analyses included repeated-measures analysis of variance (ANOVA) and a mixed-effects model to assess the influence of treatment type on rehabilitation costs.
resultsSurgery showed significant year-to-year differences (
conclusionsThis study demonstrated that although individual cancer treatments increase rehabilitation costs, treatment interactions can help mitigate these financial burdens, highlighting the importance of integrated care. Our findings support the incorporation of rehabilitation, including multidisciplinary approaches, into cancer survivorship care. Further research is needed to optimize rehabilitation planning based on treatment interactions to improve cost-efficiency and clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.